| Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease P Sen, S Qadri, PK Luukkonen, O Ragnarsdottir, A McGlinchey, S Jäntti, ... Journal of hepatology 76 (2), 283-293, 2022 | 197 | 2022 |
| Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease PK Luukkonen, S Qadri, N Ahlholm, K Porthan, V Männistö, ... Journal of hepatology 76 (3), 526-535, 2022 | 147 | 2022 |
| Development and validation of a score for fibrotic nonalcoholic steatohepatitis F Tavaglione, O Jamialahmadi, A De Vincentis, S Qadri, ME Mowlaei, ... Clinical Gastroenterology and Hepatology 21 (6), 1523-1532. e1, 2023 | 66 | 2023 |
| Obesity modifies the performance of fibrosis biomarkers in nonalcoholic fatty liver disease S Qadri, N Ahlholm, I Lønsmann, P Pellegrini, A Poikola, PK Luukkonen, ... The Journal of Clinical Endocrinology & Metabolism 107 (5), e2008-e2020, 2022 | 50 | 2022 |
| The PNPLA3-I148M variant confers an antiatherogenic lipid profile in insulin-resistant patients PK Luukkonen, S Qadri, TE Lehtimäki, A Juuti, H Sammalkorpi, ... The Journal of Clinical Endocrinology & Metabolism 106 (1), e300-e315, 2021 | 32 | 2021 |
| The PNPLA3‐I148M variant increases polyunsaturated triglycerides in human adipose tissue S Qadri, S Lallukka‐Brück, PK Luukkonen, Y Zhou, A Gastaldelli, ... Liver International 40 (9), 2128-2138, 2020 | 28 | 2020 |
| Overfeeding saturated fat increases LDL (low-density lipoprotein) aggregation susceptibility while overfeeding unsaturated fat decreases proteoglycan-binding of lipoproteins M Ruuth, M Lahelma, PK Luukkonen, MB Lorey, S Qadri, S Sädevirta, ... Arteriosclerosis, thrombosis, and vascular biology 41 (11), 2823-2836, 2021 | 27 | 2021 |
| Case reports of two pedigrees with recessive arrhythmogenic right ventricular cardiomyopathy associated with homozygous Thr335Ala variant in DSG2 S Qadri, O Anttonen, J Viikilä, EH Seppälä, S Myllykangas, TP Alastalo, ... BMC Medical Genetics 18, 1-9, 2017 | 22 | 2017 |
| Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis S Qadri, E Vartiainen, M Lahelma, K Porthan, A Tang, IS Idilman, ... JHEP reports 6 (1), 100928, 2024 | 19 | 2024 |
| Insulin-inducible THRSP maintains mitochondrial function and regulates sphingolipid metabolism in human adipocytes MA Ahonen, M Höring, VD Nguyen, S Qadri, JH Taskinen, M Nagaraj, ... Molecular Medicine 28 (1), 68, 2022 | 16 | 2022 |
| Validation of the blood test MACK-3 for the noninvasive diagnosis of fibrotic nonalcoholic steatohepatitis: an international study with 1924 patients CM Canivet, MH Zheng, S Qadri, L Vonghia, KH Chuah, C Costentin, ... Clinical gastroenterology and hepatology 21 (12), 3097-3106. e10, 2023 | 15 | 2023 |
| Assessment of lifestyle factors helps to identify liver fibrosis due to non-alcoholic fatty liver disease in obesity M Lahelma, PK Luukkonen, S Qadri, N Ahlholm, S Lallukka-Brück, ... Nutrients 13 (1), 169, 2021 | 15 | 2021 |
| Surveillance of the liver in type 2 diabetes: important but unfeasible? S Qadri, H Yki-Järvinen Diabetologia 67 (6), 961-973, 2024 | 13 | 2024 |
| SIRT5 rs12216101 T> G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease F Salomone, RM Pipitone, M Longo, F Malvestiti, AM Amorini, A Distefano, ... Journal of Hepatology 80 (1), 10-19, 2024 | 10 | 2024 |
| The human liver lipidome is significantly related to the lipid composition and aggregation susceptibility of low-density lipoprotein (LDL) particles M Lahelma, S Qadri, N Ahlholm, K Porthan, M Ruuth, A Juuti, M Orešič, ... Atherosclerosis 363, 22-29, 2022 | 10 | 2022 |
| In vitro Effects of Bacterial Exposure on Secretion of Zonulin Family Peptides and Their Detection in Human Tissue Samples C Jian, S Kanerva, S Qadri, H Yki-Järvinen, A Salonen Frontiers in Microbiology 13, 848128, 2022 | 6 | 2022 |
| Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease V Raverdy, F Tavaglione, E Chatelain, G Lassailly, A De Vincentis, ... Nature Medicine 30 (12), 3624-3633, 2024 | 5 | 2024 |
| IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids K Sasidharan, A Caddeo, O Jamialahmadi, FR Noto, M Tomasi, ... Cell Reports Medicine 5 (1), 2024 | 5 | 2024 |
| A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease Q Huang, SF Qadri, H Bian, X Yi, C Lin, X Yang, X Zhu, H Lin, H Yan, ... Journal of Hepatology, 2024 | 4 | 2024 |
| Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease RM Pipitone, F Malvestiti, G Pennisi, O Jamialahmadi, P Dongiovanni, ... Liver International 43 (8), 1761-1771, 2023 | 2 | 2023 |
Hannele Yki-JärvinenSisätautiopin professoriEmail yang diverifikasi di helsinki.fi
